Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets

Oppenheimer Initiates a Robust Process with Global Reach for the Benefit of Shareholders -REDWOOD CITY, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. NASDAQ:CHRS today announced that it has initiated the process to market and sell the remaining assets associated with the Compa…